vs
德康医疗（DXCM）与FRESH DEL MONTE PRODUCE INC（FDP）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是FRESH DEL MONTE PRODUCE INC的1.2倍（$1.3B vs $1.0B），德康医疗净利率更高（21.2% vs 3.2%，领先18.1%），德康医疗同比增速更快（21.6% vs 0.6%），过去两年德康医疗的营收复合增速更高（12.0% vs -4.1%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
鲜德尔蒙农产品公司是全球领先的垂直一体化生鲜及鲜切果蔬、加工果蔬生产、分销及营销企业，注册地位于开曼群岛乔治敦，美国行政总部设在佛罗里达州科勒尔盖布尔斯塞维利亚大道241号。
DXCM vs FDP — 直观对比
营收规模更大
DXCM
是对方的1.2倍
$1.0B
营收增速更快
DXCM
高出21.0%
0.6%
净利率更高
DXCM
高出18.1%
3.2%
两年增速更快
DXCM
近两年复合增速
-4.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.0B |
| 净利润 | $267.3M | $32.3M |
| 毛利率 | 62.9% | 10.4% |
| 营业利润率 | 25.6% | 4.5% |
| 净利率 | 21.2% | 3.2% |
| 营收同比 | 21.6% | 0.6% |
| 净利润同比 | 153.6% | 59.1% |
| 每股收益（稀释后） | $0.67 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMFDP
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.2B | $1.0B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $1.1B | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $994.2M | $1.0B | ||
| Q2 24 | $1.0B | $1.1B |
净利润DXCMFDP
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $32.3M | ||
| Q3 25 | $283.8M | $-29.1M | ||
| Q2 25 | $179.8M | $56.8M | ||
| Q1 25 | $105.4M | $31.1M | ||
| Q4 24 | $151.7M | $20.3M | ||
| Q3 24 | $134.6M | $42.1M | ||
| Q2 24 | $143.5M | $53.6M |
毛利率DXCMFDP
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 10.4% | ||
| Q3 25 | 60.5% | 7.9% | ||
| Q2 25 | 59.5% | 10.2% | ||
| Q1 25 | 56.9% | 8.4% | ||
| Q4 24 | 58.9% | 6.8% | ||
| Q3 24 | 59.7% | 9.2% | ||
| Q2 24 | 62.4% | 9.9% |
营业利润率DXCMFDP
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 4.5% | ||
| Q3 25 | 20.1% | -2.1% | ||
| Q2 25 | 18.4% | 5.8% | ||
| Q1 25 | 12.9% | 4.1% | ||
| Q4 24 | 17.0% | 3.0% | ||
| Q3 24 | 15.3% | 5.3% | ||
| Q2 24 | 15.7% | 6.0% |
净利率DXCMFDP
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 3.2% | ||
| Q3 25 | 23.5% | -2.8% | ||
| Q2 25 | 15.5% | 4.8% | ||
| Q1 25 | 10.2% | 2.8% | ||
| Q4 24 | 13.6% | 2.0% | ||
| Q3 24 | 13.5% | 4.1% | ||
| Q2 24 | 14.3% | 4.7% |
每股收益（稀释后）DXCMFDP
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.67 | ||
| Q3 25 | $0.70 | $-0.61 | ||
| Q2 25 | $0.45 | $1.18 | ||
| Q1 25 | $0.27 | $0.64 | ||
| Q4 24 | $0.37 | $0.41 | ||
| Q3 24 | $0.34 | $0.88 | ||
| Q2 24 | $0.35 | $1.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $35.7M |
| 总债务越低越好 | — | $176.2M |
| 股东权益账面价值 | $2.7B | $2.0B |
| 总资产 | $6.3B | $3.1B |
| 负债/权益比越低杠杆越低 | — | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资DXCMFDP
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $35.7M | ||
| Q3 25 | $1.8B | $97.2M | ||
| Q2 25 | $1.2B | $85.5M | ||
| Q1 25 | $904.9M | $34.4M | ||
| Q4 24 | $606.1M | $32.6M | ||
| Q3 24 | $621.2M | $50.8M | ||
| Q2 24 | $939.2M | $37.8M |
总债务DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | — | $176.2M | ||
| Q3 25 | — | $176.7M | ||
| Q2 25 | — | $205.2M | ||
| Q1 25 | — | $237.4M | ||
| Q4 24 | — | $248.9M | ||
| Q3 24 | — | $274.8M | ||
| Q2 24 | — | $290.4M |
股东权益DXCMFDP
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.0B | ||
| Q3 25 | $2.7B | $2.0B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.4B | $2.0B |
总资产DXCMFDP
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $3.1B | ||
| Q3 25 | $7.5B | $3.1B | ||
| Q2 25 | $7.3B | $3.2B | ||
| Q1 25 | $6.8B | $3.2B | ||
| Q4 24 | $6.5B | $3.1B | ||
| Q3 24 | $6.4B | $3.2B | ||
| Q2 24 | $6.8B | $3.1B |
负债/权益比DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $10.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-17.2M |
| 自由现金流率自由现金流/营收 | — | -1.7% |
| 资本支出强度资本支出/营收 | — | 2.8% |
| 现金转化率经营现金流/净利润 | — | 0.34× |
| 过去12个月自由现金流最近4个季度 | — | $181.3M |
8季度趋势，按日历期对齐
经营现金流DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $10.9M | ||
| Q3 25 | $659.9M | $75.0M | ||
| Q2 25 | $303.0M | $113.1M | ||
| Q1 25 | $183.8M | $46.1M | ||
| Q4 24 | $301.4M | $-4.7M | ||
| Q3 24 | $199.5M | $43.5M | ||
| Q2 24 | $279.4M | $125.0M |
自由现金流DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $-17.2M | ||
| Q3 25 | $579.4M | $60.9M | ||
| Q2 25 | $208.9M | $101.5M | ||
| Q1 25 | $96.8M | $36.1M | ||
| Q4 24 | $176.8M | $-22.3M | ||
| Q3 24 | $88.3M | $30.1M | ||
| Q2 24 | $213.3M | $117.0M |
自由现金流率DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -1.7% | ||
| Q3 25 | 47.9% | 6.0% | ||
| Q2 25 | 18.1% | 8.6% | ||
| Q1 25 | 9.3% | 3.3% | ||
| Q4 24 | 15.9% | -2.2% | ||
| Q3 24 | 8.9% | 3.0% | ||
| Q2 24 | 21.2% | 10.3% |
资本支出强度DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 2.8% | ||
| Q3 25 | 6.7% | 1.4% | ||
| Q2 25 | 8.1% | 1.0% | ||
| Q1 25 | 8.4% | 0.9% | ||
| Q4 24 | 11.2% | 1.7% | ||
| Q3 24 | 11.2% | 1.3% | ||
| Q2 24 | 6.6% | 0.7% |
现金转化率DXCMFDP
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 0.34× | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | 1.99× | ||
| Q1 25 | 1.74× | 1.48× | ||
| Q4 24 | 1.99× | -0.23× | ||
| Q3 24 | 1.48× | 1.03× | ||
| Q2 24 | 1.95× | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
